Galletta Christopher
Insider CIK 1486099 · TACT Corporate Controller · TRVI See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-02-19 | 2026-02-20 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-12-02 | 2025-12-03 | 4,225 | — | $0 | 15,775 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-12-02 | 2025-12-03 | 4,225 | $0.51 | $2.2K | 26,095 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-05-31 | 2025-06-03 | 8,550 | — | $0 | 13,110 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-03-10 | 2025-03-12 | 4,560 | — | $0 | 4,560 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 41,000 | — | $0 | 41,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-12-13 | 2024-12-17 | 15,000 | — | $0 | 20,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-12-13 | 2024-12-17 | 15,000 | $0.51 | $7.7K | 19,935 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-16 | 28,500 | — | $0 | 28,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-04-13 | 2021-04-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TACT TRANSACT TECHNOLOGIES INC | M Exercise deriv | 2012-01-02 | 2012-01-04 | 500 | $2.18 | $1.1K | 0 | SEC↗ |
| TACT TRANSACT TECHNOLOGIES INC | M Exercise | 2012-01-02 | 2012-01-04 | 500 | $2.18 | $1.1K | 500 | SEC↗ |